Detalhe da pesquisa
1.
Outcomes of Patients With Inflammatory Bowel Diseases Switched From Maintenance Therapy With a Biosimilar to Remicade.
Clin Gastroenterol Hepatol
; 17(12): 2506-2513.e2, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30630103
2.
Therapeutic preferences and outcomes in newly diagnosed patients with Crohn's diseases in the biological era in Hungary: a nationwide study based on the National Health Insurance Fund database.
BMC Gastroenterol
; 18(1): 23, 2018 Jan 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-29378524
3.
Burden of Mental Health among Patients with Inflammatory Bowel Disease-A Cross-Sectional Study from a Tertiary IBD Center in Hungary.
J Clin Med
; 13(7)2024 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38610767
4.
Burden of perianal disease in Crohn's disease: Accelerating medical therapy and high rates of perianal surgery over the last four decades - Results from a population-based study over four decades.
Aliment Pharmacol Ther
; 59(5): 656-665, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38115207
5.
[Esophageal candidiasis as an indicator condition]. / Candidaoesophagitis mint indikátorbetegség.
Orv Hetil
; 164(22): 878-880, 2023 Jun 04.
Artigo
em Húngaro
| MEDLINE | ID: mdl-37270771
6.
Objective Disease Monitoring Strategies from a Tertiary Inflammatory Bowel Disease Center in Hungary.
Turk J Gastroenterol
; 34(5): 508-515, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36620930
7.
Declining Trends of Reoperations and Disease Behaviour Progression in Crohn's Disease over Different Therapeutic Eras-A Prospective, Population-Based Study from Western Hungary between 1977-2020, Data from the Veszprem Cohort.
J Crohns Colitis
; 17(12): 1980-1987, 2023 Dec 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37422727
8.
Malignant solid tumor associated with hypereosinophilic syndrome / Malignus solid tumorhoz társuló hypereosinophil szindróma
Orv Hetil
; 163(44): 1758-1762, 2022 Oct 30.
Artigo
em Húngaro
| MEDLINE | ID: mdl-36309891
9.
Non-medical switch from the originator to biosimilar and between biosimilars of adalimumab in inflammatory bowel disease - a prospective, multicentre study.
Dig Liver Dis
; 54(12): 1639-1645, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35931624
10.
Ustekinumab is associated with superior treatment persistence but not with higher remission rates versus vedolizumab in patients with refractory Crohn's disease: results from a multicentre cohort study.
Therap Adv Gastroenterol
; 15: 17562848221144349, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36600684
11.
Clinical efficacy, drug sustainability and serum drug levels in Crohn's disease patients treated with ustekinumab - A prospective, multicenter cohort from Hungary.
Dig Liver Dis
; 54(2): 207-213, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34344576
12.
Incidence, Predictive Factors, Clinical Characteristics and Outcome of Non-variceal Upper Gastrointestinal Bleeding - A Prospective Population-based Study from Hungary.
J Gastrointestin Liver Dis
; 30(3): 327-333, 2021 09 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34375379
13.
Outcomes of variceal upper gastrointestinal bleeding: A prospective, multicenter, population-based study from West Hungary / A varixeredetu felso gastrointestinalis vérzések elemzése: yugat-magyarországi prospektív, multicentrikus, népességalapú vizsgálat
Orv Hetil
; 162(31): 1252-1259, 2021 08 01.
Artigo
em Húngaro
| MEDLINE | ID: mdl-34333456
14.
Anti-TNF dose escalation and drug sustainability in Crohn's disease: Data from the nationwide administrative database in Hungary.
Dig Liver Dis
; 52(3): 274-280, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31669077
15.
Biosimilars in IBD: Will it Benefit to Patients, Physicians or the Health Care System?
Curr Pharm Des
; 25(1): 13-18, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30864504
16.
Editorial: The prevalence and outcomes of perianal Crohn's disease across the treatment eras-Authors' reply.
Aliment Pharmacol Ther
; 59(5): 715-716, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38349708
17.
[The role of fecal calprotectin in the diagnosis and treatment of gastrointestinal diseases]. / A székletkalprotektin meghatározásának szerepe a bélbetegségek diagnosztikájában és kezelésében.
Orv Hetil
; 160(9): 322-328, 2019 Mar.
Artigo
em Húngaro
| MEDLINE | ID: mdl-30798622
18.
Biosimilars in ulcerative colitis: When and for who?
Best Pract Res Clin Gastroenterol
; 32-33: 35-42, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30060937
19.
Letter: Experience of switching vedolizumab treatment from intravenous to subcutaneous formulation in Hungary.
Aliment Pharmacol Ther
; 58(2): 262-263, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37352154
20.
[Analysis of work productivity and quality of life in patients with inflammatory bowel disease]. / A gyulladásos bélbetegségek társadalmi hatásai: a munkaképesség és az életminoség vizsgálata.
Orv Hetil
; 164(50): 1974-1984, 2023 12 17.
Artigo
em Húngaro
| MEDLINE | ID: mdl-38108857